Healthcare | April 20, 2026
Energy drinks emerging as hidden driver of liver damage in India’s youth, warn experts
Medical experts point to a growing body of research linking energy drinks to liver injury
Medical experts point to a growing body of research linking energy drinks to liver injury
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
The trial, dubbed MALBEC, marks the first in a broader late-phase development push for MK-8748, with a second NVAMD study expected to begin later this year
The showcase, running March 27–31, puts a spotlight on everything from fine lines to daily sun protection
The therapy works by targeting interleukin-13, a key driver of inflammation behind eczema symptoms such as itching, skin damage, and infection
It promises fewer injections for vision loss patients
The trial met its primary endpoint, with the combination therapy demonstrating a “statistically significant and clinically meaningful” improvement in radiographic progression-free survival
Subscribe To Our Newsletter & Stay Updated
